These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11049737

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa.
    Jenny RJ, Mann KG, Lundblad RL.
    Protein Expr Purif; 2003 Sep; 31(1):1-11. PubMed ID: 12963335
    [Abstract] [Full Text] [Related]

  • 3. Processing of fusion proteins with immobilized factor Xa.
    Assouline Z, Graham R, Miller RC, Warren AJ, Kilburn DG.
    Biotechnol Prog; 1995 Sep; 11(1):45-9. PubMed ID: 7765987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
    Fischer BE, Mitterer A, Schlokat U, Grillberger L, Reiter M, Mundt W, Dorner F, Eibl J.
    Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner.
    Peter K, Gupta A, Nordt T, Bauer S, Runge MS, Bode C.
    J Cardiovasc Pharmacol; 2003 Aug; 42(2):237-44. PubMed ID: 12883328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Construction and expression of a fusion protein made of tissue-type plasminogen activator and hirudin in Pichia pastoris].
    Yu AP, Shi BX, Dong CN, Jiang ZH, Wu ZZ.
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):553-7. PubMed ID: 16176091
    [Abstract] [Full Text] [Related]

  • 14. Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition.
    Roddick LA, Bhakta V, Sheffield WP.
    BMC Biochem; 2013 Nov 11; 14():31. PubMed ID: 24215622
    [Abstract] [Full Text] [Related]

  • 15. High-level secretion of hirudin by Hansenula polymorpha--authentic processing of three different preprohirudins.
    Weydemann U, Keup P, Piontek M, Strasser AW, Schweden J, Gellissen G, Janowicz ZA.
    Appl Microbiol Biotechnol; 1995 Dec 11; 44(3-4):377-85. PubMed ID: 8597538
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV, Petrovan RJ, Ruf W, Olson AJ.
    Proteins; 2003 Nov 15; 53(3):640-8. PubMed ID: 14579355
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hirudin as a novel fusion tag for efficient production of lunasin in Escherichia coli.
    Tian Q, Zhang P, Gao Z, Li H, Bai Z, Tan S.
    Prep Biochem Biotechnol; 2017 Jul 03; 47(6):619-626. PubMed ID: 28151045
    [Abstract] [Full Text] [Related]

  • 20. C-terminal proteolytic degradation of recombinant desulfato-hirudin and its mutants in the yeast Saccharomyces cerevisiae.
    Heim J, Takabayashi K, Meyhack B, Märki W, Pohlig G.
    Eur J Biochem; 1994 Dec 01; 226(2):341-53. PubMed ID: 8001551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.